# NeuroSparkABA — Researched ABA Needs Guide: Source Note

**Prepared:** November 2, 2026  
**Chosen topic:** Family-and-school planning for wandering / leaving supervision  
**Scope:** General education only. The guide is not a diagnosis, individualized risk assessment, treatment plan, or substitute for local emergency guidance.

## Why this topic was selected

I compared three evidence-supported needs: wandering safety, sleep support, and assent in ABA services. This is a practical first-guide choice, not a universal ranking of need or impact.

Wandering was selected because it has a direct safety signal, cross-setting relevance, and current authoritative caregiver/educator guidance. In a nationally representative, cross-sectional analysis of the 2011 CDC Pathways survey, parents of 3,518 U.S. school-age children with autism and/or intellectual disability or developmental delay reported that 26.7% had wandered during the prior year; wandering most often occurred in public places [1]. A separate, earlier online parent survey of 1,218 autistic children found that 49% had attempted to wander after age four. Among children who went missing long enough to concern caregivers, 24% were reported to be in danger of drowning and 65% were reported to be in danger of traffic injury; caregivers also described disrupted sleep and avoiding outings [2]. These are different populations and time windows, so their percentages are not directly comparable or evidence of a trend. Both estimates rely on parent reports, and the family survey used volunteer online participants.

The CDC's current wandering page was reviewed January 29, 2026. It describes wandering as a safety issue and offers planning, prevention, and safety-skill suggestions for caregivers, educators, providers, and responders [3]. Its prevalence statement draws on the older Anderson et al. survey, rather than a new 2026 prevalence study. This makes the guidance current while the prevalence evidence remains dated.

The ABA-specific literature makes the topic relevant to behavior support while also setting clear limits. Boyle and Adamson's systematic review covered only studies published from 2000 through 2015 and included 12 studies, largely small single-case evaluations [4]. It found that the circumstances associated with leaving varied; a person's behavior should not be assigned one presumed function based on a label or a single incident. A more recent retrospective inpatient case series examined 17 treatments for 14 autistic children [5]. It is useful as an example of specialized, individualized clinical research, but its small inpatient sample cannot establish what will work in a home, classroom, or community setting.

Sleep and assent remain important needs and are not ranked lower by this selection. Sleep has an American Academy of Neurology practice guideline, based on evidence reviewed through December 2017 [6], and a systematic review of only three small controlled trials [7]. Assent is directly relevant to ethical ABA service delivery; Breaux and Smith offer ABA/PBS-specific ethical and practical recommendations, while noting that empirical work remains limited [8]. The choice here reflects the immediate safety stakes and the availability of shared family-school planning actions, not evidence that wandering is more prevalent or important than sleep or assent.

## Evidence strength and limits

- **Importance of safety planning: well supported as a documented concern.** A nationally representative parent survey and a separate autism-family survey identify wandering and safety exposure. Both are parent reports; the national dataset is cross-sectional and comes from 2011, and the family-impact sample was voluntary and online.
- **Current general safety guidance: authoritative, not a trial of effectiveness.** CDC recommendations are practical public-health guidance. They do not establish that any one checklist or strategy prevents every incident.
- **ABA-specific assessment/treatment evidence: promising but narrow.** The systematic review contains small, mostly single-case studies with a search period ending in 2015. The 2024 online / 2025 journal case series was retrospective and inpatient. Neither supports a universal ABA protocol or predicts individual outcomes.
- **The guide's worksheet and examples: practical suggestions.** They organize the CDC's plan / prevent / teach guidance and encourage accessible communication, clear supervision roles, and neutral context notes. They are not a validated tool and are not presented as proven treatment.

## How the guide keeps advice safe

The PDF uses "wandering" and "leaving supervision" as plain descriptions, noting that research often uses "elopement." It gives no diagnosis, inferred behavioral function, individualized clinical direction, or promised outcome. It does not recommend testing or deliberately arranging an opportunity to leave. Functional assessment and treatment belong with an appropriately qualified professional using safeguards. The guide stresses that a practiced safety response cannot replace active adult supervision, and that environmental safeguards must preserve emergency egress and the person's access to communication and support. Immediate danger requires prompt use of local emergency services.

## Sources

1. Kiely B, Migdal TR, Vettam S, Adesman A. Prevalence and Correlates of Elopement in a Nationally Representative Sample of Children with Developmental Disabilities in the United States. *PLoS ONE*. 2016;11(2):e0148337. [https://doi.org/10.1371/journal.pone.0148337](https://doi.org/10.1371/journal.pone.0148337). Cross-sectional secondary analysis of 2011 CDC Pathways data; 3,518 children with ASD and/or cognitive impairment; 26.7% reportedly wandered in the prior year.
2. Anderson C, Law JK, Daniels A, Rice C, Mandell DS, Hagopian L, Law PA. Occurrence and Family Impact of Elopement in Children With Autism Spectrum Disorders. *Pediatrics*. 2012;130(5):870-877. [https://doi.org/10.1542/peds.2012-0762](https://doi.org/10.1542/peds.2012-0762). Parent online questionnaire, including 1,218 children with autism and 1,076 siblings; convenience / volunteer sample limits population generalization.
3. Centers for Disease Control and Prevention. Wandering (Elopement). *Child Development*. Published May 15, 2024; page updated July 31, 2025; reviewed January 29, 2026. [https://www.cdc.gov/child-development/disability-safety/wandering.html](https://www.cdc.gov/child-development/disability-safety/wandering.html).
4. Boyle MA, Adamson RM. Systematic Review of Functional Analysis and Treatment of Elopement (2000-2015). *Behavior Analysis in Practice*. 2017;10(4):375-385. [https://doi.org/10.1007/s40617-017-0191-y](https://doi.org/10.1007/s40617-017-0191-y). Review of 12 eligible studies; search period ended in 2015.
5. Nevill RE, Crawford MF, Zarcone JR, Maquera ES, Rooker GW, Schmidt JD. A Retrospective Consecutive Controlled Case Series Analysis of the Assessment and Treatment of Elopement in Children with Autism in an Inpatient Setting. *Behavior Analysis in Practice*. 2025;18:903-920. Published online October 24, 2024. [https://doi.org/10.1007/s40617-024-00979-1](https://doi.org/10.1007/s40617-024-00979-1). Retrospective analysis of 17 treatments for 14 children in an inpatient setting; not a community effectiveness study.
6. Williams Buckley A, Hyman SL, McDougle CJ, et al. Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder. *Neurology*. 2020;94(9):392-404. [https://doi.org/10.1212/WNL.0000000000009033](https://doi.org/10.1212/WNL.0000000000009033). Guideline evidence review included studies through December 2017; reaffirmed by the American Academy of Neurology in 2026.
7. Keogh S, Bridle C, Siriwardena NA, Nadkarni A, Laparidou D, Durrant SJ, Kargas N, Law GR, Curtis F. Effectiveness of non-pharmacological interventions for insomnia in children with Autism Spectrum Disorder: A systematic review and meta-analysis. *PLoS ONE*. 2019;14(8):e0221428. [https://doi.org/10.1371/journal.pone.0221428](https://doi.org/10.1371/journal.pone.0221428). Three small controlled trials; limited evidence base and variation in measures.
8. Breaux CA, Smith K. Assent in applied behaviour analysis and positive behaviour support: ethical considerations and practical recommendations. *International Journal of Developmental Disabilities*. 2023;69(1):111-121. [https://doi.org/10.1080/20473869.2022.2144969](https://doi.org/10.1080/20473869.2022.2144969). ABA / PBS-focused ethical and practical article; not an outcomes meta-analysis.

## Brand review

The supplied brand-board PNG was downloaded and visually inspected on November 2, 2026. The guide uses the board's Deep Neural (`#0B1D2A`), Neuro Aqua (`#1ECAD3`), Spark Purple (`#7B61FF`), Growth Green (`#22C39A`), Clarity Blue (`#2A8BFF`), and Soft Cloud (`#F4F6FA`) palette; a dark/light balance, generous spacing, restrained luminous neural/floral linework, and the board's clean Avenir Next-style sans-serif direction. It avoids using unverified third-party marks or implying any source endorses NeuroSparkABA.